When tumors reached a mean group size of approximately 100 mm3, the mice were matched for tumor volumes and assigned to CHOP siRNA, thapsigargin and hrTRAIL co-treatment, or combination treatment with these three agents (Fig. 13A). Here, DDIT3 is linked to neoplasm.